According to Fulgent Genetics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.28768. At the end of 2023 the company had a P/S ratio of 2.96.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.96 | 103.7% |
2022 | 1.45 | -51.9% |
2021 | 3.02 | -13.16% |
2020 | 3.48 | -59.14% |
2019 | 8.52 | 215.78% |
2018 | 2.70 | -35.27% |
2017 | 4.17 | -62.75% |
2016 | 11.2 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
PAVmed
PAVM | 6.89 | 200.97% | ๐บ๐ธ USA |
Philips PHG | 1.33 | -41.64% | ๐ณ๐ฑ Netherlands |